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ABSTRACT 
The ability of cancer cells to synthesize and store lipids in the form of lipid droplets (LDs) gives 
them a proliferative advantage over normal cells. Here, we elucidate the effect of 
monoethanolamine (Etn) on the lipid metabolism of LD-rich prostate carcinoma (PC3) cells. Etn 
is a ubiquitous molecule that serves as a phospholipid precursor and has been shown to have 
anticancer activity, although its mechanism of action is not fully understood. PC3 cells were 
treated with Etn and evaluated with a combination of biochemical and cell biology techniques. 
Treatment with Etn caused a decrease in cytosolic LD abundance induced by Ca2+-stimulated 
lipolysis. Our study effectively implicates the disruption of lipid metabolism as a contributor to 
Etn-induced cell death. This finding opens new avenues for the development of LD-targeted 
anticancer therapy. 
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1 INTRODUCTION  
1.1 Background  
1.1.1 Cancer and society 
Cancer is the second leading cause of death in the United States and is one of the most 
prevalent diseases in the developed world[1], [2], [3]. It is the name given to a group of diseases in 
which the body’s cells begin to divide without any checks or balances to stop their proliferation 
and spread into surrounding tissues[1]. It can arise almost anywhere in the body and be composed 
of any type of cell. Because of their accelerated growth rate, it can quickly outnumber and force 
out the “normal” cells within the tissue, forming a tumor.  
Under normal conditions, cells undergo a natural death process. When the cell has found 
itself inviable due to abnormalities in shape, function or DNA damage, released signals force the 
defective unit to proceed into a programmed cell death[4]. These programmed cell deaths can 
include apoptosis or autophagy[5]. Necrosis, a third type of cell death, only arises as a result of 
infection or injury[4]. Cancerous cells, however, find alternative pathways to circumvent 
programmed cell death, allowing them to continue replicating, unhindered[6]. This leaves 
researchers searching for ways in which to induce appropriate death progressions to halt tumor 
growth and cancerous invasion.  
Effective treatment for these diseases can vary greatly throughout tissue type and cell 
subtype due to the vast array of surface markers and alternate pathways for cancer cell survival[6]. 
Additionally, current cancer treatments aim to inhibit cell proliferation, incurring in negative side-
effects, such as the death and slow cell growth of healthy, normal cells[6]. This type of treatment 
leads to the debilitated, sick state often associated with cancer patients undergoing aggressive 
chemotherapy[7]. Therefore, the field of cancer research has been interested in finding targeted 
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approaches, aimed at attacking molecules within the cancer cells that might trigger pathways of 
natural cell death.  
1.1.2 Unique molecular patterns of cancer cells 
As mentioned earlier, cancer cells employ the use of several alternative living pathways in 
order to ensure their survival. These alterations become the biochemical foundation of the cell’s 
tumor-building capacity, aggressiveness and potential for metastasis [8]. Some of the alternative 
metabolisms favored by cancer cells are aerobic glycolysis, glutamine dependent anaplerosis, 
which allow cells to migrate from the primary tumor and become viable metastases, and de novo 
lipid generation[8].  
Lipid metabolism has been well characterized within cancer cells[9], [10]. The major 
component of cell membranes are phospholipids, along with other integral lipids, such as sterols 
and sphingolipids. Due to the constantly replicating nature of cancer cells, they require a steady 
supply of both structural and energy-providing lipids[10]. This need is what has prompted cancer 
cells to develop the ability to undergo de novo lipogenesis, an ability possessed by only liver, 
adipose, and lactating breast tissue once the organism enters adulthood[11]. The cells activate lipid 
anabolic metabolism and attached signaling for subsequent generation of new membranes, storage 
of energy and as a primary energy source (via fatty acid oxidation) during energy-deficient 
periods[8].  
The cycling of fatty acids (FA) for structural and energetic purposes lies at the center of 
the lipid metabolism network[10]. These FA can generate metabolic intermediates used in anabolic 
processes for membrane building blocks or as signaling molecules to activate oncogenic 
cascades[8] [10]. The balance of FA synthesis and FA oxidation is imperative for the survival of 
cancer cells. FA are created and stored in reservoirs, known as lipid droplets (LDs), which remain 
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inactive until needed by the cell. Following the degradation of these LDs, the components created 
during FA oxidation can aid in the synthesis of membranes, ATP and NADPH required for other 
processes, and can be used as building blocks for another round of FA synthesis[12] [13] [14] [15]. 
Because of its important role in cancer cell survival the targeting of lipid metabolism by anticancer 
medication could very well be the next target for chemotherapies.  
1.1.3 Lipid droplets 
The demand for FA storage vessels in cancer cells defines a major morphological 
trademark in cell pathology. In order to have these base materials handy, the cells have employed 
the use of a special compartment called lipid droplets (LDs), a naturally-occurring organelles that 
can be found among most eukaryotic cell types[15]. They consist of a phospholipid monolayer 
studded with integral proteins such as perilipins, that surround a core of triglycerides and sterols. 
The perilipins allow for the droplets to be enzymatically degraded, so that its contents can be 
quickly processed for whatever purposes they are needed[15].  
It is known that, with the exception of adipocytes, cancer cells possess a higher abundance 
of these reservoirs, generally of significantly greater size, than normal cell types[10] [16]. While 
adipocytes use these LDs as more or less static storage units, cancer cells have developed a 
dynamic life cycle for these vesicles[14]. Due to these differences in metabolic fates, LDs in adipose 
cells are large and few in number, taking up most of the volume of the cell, while the same 
organelles in cancer cells are both smaller and more abundant[12] [14]. Their smaller size increases 
their surface to volume ratio, increasing the rate at which they can be degraded and formed[14].  
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Figure 1.1.1 Schematic representation of lipid droplet structure and its fates 
 
Although there is no definitive mechanism for the creation of LDs, the most compelling 
model states that LDs are created in the endoplasmic reticulum (ER), through a mechanism named 
membrane budding [12] [13] [14] [15]. Neutral fatty acids, such as triglycerides and sterols are 
synthesized in the ER where the components form a film against the membrane[12] [14]. The 
phospholipid membrane forms a leaflet that then invaginates the neutral lipids of the core before 
dissociating from the rest of the ER[12]. This results in the creation of a monolayered vacuole with 
a core of neutral lipids that adopts a naturally round shape. Alternative theories posit that LDs are 
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extricated from both leaflets of the ER, giving rise to a bicelle[12]. Some scientists favor this theory 
due to the abundance of surface proteins that seemingly are related to several ER processes[14]. 
Regardless of how the LDs arise, their presence allows cancer cells to have all the materials 
they need for rapid proliferation readily available, cutting down on division time and expended 
energy[15]. In order to unpack the components within LDs, intracellular lipases must hydrolyze the 
core lipids. These lipids can then be oxidized by the mitochondria to create ATP[14] [15]. 
Alternatively, they can be shipped elsewhere in the cell for other purposes. In the case of 
triglycerides (TGs), their release is governed by hormones and activation of protein kinase A 
(PKA)[15]. PKA phosphorylates the proteins perilipin and hormone-sensitive lipase (HSL), present 
on the LD surface[12] [15] [14]. This activates a catabolic cascade that ends in the hydrolysis of TGs 
into fatty acids and glycerol that must be released from the cytosol to avoid cell toxicity[14] [12, 17].  
Considering the range of functions which LDs serve in cancer cells, it would help to 
consider these reservoirs as ideal targets for anticancer treatments. By focusing action on 
metabolically active LDs, normal cells with little to no lipid droplets, and those with LDs with 
more static metabolisms would be largely unscathed[18].  
1.1.4 Monoethanolamine and its anticancer effects 
In cells, the balance of FAs, phospholipids and other lipids is kept through the 
interconnection of lipid biosynthesis and the Kennedy pathways[18]. Within these pathways, 
materials broken down into acetyl-CoA from glycolysis or oxidation are reduced to FAs. These 
molecules are then either converted to FA-CoA and transported to the mitochondria for oxidation 
or made into phospholipids and exported to the membrane. Disruption of this balance, either by 
blocking signaling cascades or the sequestration and introduction of materials, would have major 
implications in cell function and survival.  
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Previously, our lab has characterized the anticancer effect of monoethanolamine (Etn) on 
different cancer cell lines. Etn is a small, polar molecule, that serves as a precursor within the 
Kennedy phospholipid biosynthesis pathway[19]. Once this molecule is phosphorylated to form 
phosphoethanolamine (PhosE), it can continue down the pathway to create 
phosphatidylethanolamine (PE), the second most abundant phospholipid present in cells[20] [19] [21]. 
Due to its ties to these pathways, it is possible that the drug’s efficacy in vitro is due to a 
dysregulation within the lipid metabolism[22]. Therefore, the purpose of this study was to evaluate 
the effect of Etn treatment on a prostate cancer cell line (PC3-luc) signaling mechanisms and its 
plausible effects on lipid metabolism.   
 
1.2 Overall Objectives  
The purpose of this thesis work is to identify the physical and molecular changes relating 
to the accumulation, storage and metabolism of lipids within prostate cancer cells as a direct result 
of Etn treatment. To achieve this objective, work will be split up into four aims: 
• Aim 1: Histological evaluation of changes in lipid content 
• Aim 2: Signaling changes in PC3 cells  
• Aim 3: Identification of key players in lipid metabolism-related cell death 
• Aim 4: Molecular changes in PC3 cells  
1.3 Hypothesis 
The effectiveness of Etn as an anticancer substance has been proven in previous work. This 
drug triggers apoptotic death through the activation of pathways and causes shifts in the abundance 
of molecules, namely phospholipids, which are intimately related to the lipid pathways. Therefore, 
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we believe that a portion of Etn’s killing potential lies in its ability to disrupt lipid metabolism in 
a manner that induces cell death.   
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2 AIM 1: MORPHOLOGICAL EVALUATION OF CHANGES IN LIPID CONTENT 
2.1 Introduction  
Morphological evaluation of cells has, historically, been a tool used to determine cell structure and 
function. Because structure and function are closely related, the study of tissues under the 
microscope, whether stained or unstained, has been a historically used practice to describe and 
compare cell types or differences between cells[23]. Before the development of biochemical 
techniques, histology was used to determine the malignancy of abnormal-looking tissues. The idea 
behind this evaluation is that, because normal structure of tissue had been characterized, any 
anomaly can be readily identified and attributed to disease.  Today, with the use of affinity-based 
stains, markers, and biochemical assays, we can extract more information from cell and tissue 
samples than ever before. However, the observation of general morphology of the cells in question 
still serves as a primary technique to test for differences between two samples.  
Individual cancer lines have been developed and immortalized from tumor sources and 
evaluated both geno- and phenotypically[24]. As such, every cancer type has a certain morphology 
it follows depending on what tissue it originates from, its capabilities for metastasis, its dependence 
on adhesion for survival, and whether or not it lives in clusters or single cell populations. The 
importance of this information is not only to help identify cancerous cells apart from “normal” 
tissue, but to assess whether or not an intended treatment is having any effect on the essential 
processes of the cell, changing its characteristics to make it unsuitable for further replication, and 
eventually dying. This type of characterization has been done for the model cell used in this paper, 
a prostate cancer cell line derived from a bone metastasis, PC3.  
The prostatic carcinoma cell line (PC3) was established in 1979 by Kaighn, et al. They 
reported of an epithelial cell line that originally derived from the human prostate and could invade 
9 
bone to form metastases that they thought would be “useful in investigating the biochemical 
changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic 
agents.[25]” This cell line, while anchorage independent, was well suited for growing in 
monolayers, agar, 3D soft matrices and suspension. PC3 cells flourish above normal prostate cells 
in their reduced need for serum and their independence of androgen-specific hormones and growth 
factors[25]. They are generally spindle-shaped and will anchor flat to the tissue culture surface when 
grown in monolayer and tend to form close-clustering colonies. These cells also bear physical 
resemblance to other neoplastic cells with features such as abnormal nuclei, abnormal 
mitochondria, annulate lamellae and lipoidal bodies[25]. 
This last feature, the presence of lipoidal bodies, more commonly known as lipid droplets 
(LDs), has been the basis for research in several fields, including obesity, diabetes, neuroscience, 
and cancer[12] [15]. They are cytoplasmic organelles that consist of a phospholipid monolayer 
studded with integral proteins such as perilipins, that surround a core of triglycerides and sterols[15] 
[14]. It has been shown that these fatty acids extracted through LD hydrolysis has been shown to be 
incorporated more efficiently into critical pathways compared to those taken up by the cell from 
the extracellular environment[15]. LDs allow cancer cells to have all the materials they need for 
rapid proliferation readily available, cutting down on division time, expended energy and making 
energy sources available for the cell’s use. The importance of this structure in the survival of cancer 
cells make it an ideal target for therapeutics.  
In monolayer tissue culture, LDs can be visualized through the use of staining techniques 
and high magnification imaging. Oil Red-O (ORO) is a diazol dye that stains neutral lipid and 
cholesteryl esters in bright red but does not stain biological membranes. This diazol dye has little 
affinity for the solvent that it is in, a mixture of miscible alcohol and water, but has high affinity 
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for lipids, especially those found within LDs[26]. This effectively incorporates the dye into the cell 
and tags all of the reservoirs. The addition of a counterstain, such as hematoxylin for nuclear and 
cytoplasmic differentiation allows to distinguish LDs within the cell, as opposed to LDs released 
by lysed cells that have not been removed from the slide with the washing steps.  
Following fixing and staining of the monolayer cultures, cells can be visualized on a 
brightfield microscope with a high magnification, such as 100 x. Because the dye can be visualized 
within the visible light spectrum, there is no need for lasers or specialized lamps in order to 
quantitate the results. Additionally, through the image acquisition of several fields of view (FOV) 
per sample, the relative density of LDs per FOV can be calculated. This is achieved through the 
use of the National Institute of Health’s (NIH) software, ImageJ[27]. Essentially, the amount of red 
within an image, or “positive ORO staining area” is measured relative to the amount of blue 
counterstain, or “total area occupied by a cell”, under a set of permanent parameters[28]. This 
staining and image quantification technique is a low-cost, robust, quantitative manner to identify 
average amount of lipid staining in cancer cells whether they be grown under normal conditions 
or with the addition of a therapeutic. 
Treatment of prostate cancer cells with exogenous Etn has been shown to induce apoptosis 
in prostate cancer cells[19]. Within the cell Etn is one of many molecules involved in the 
phospholipid biosynthesis pathway. Its metabolism yields the creation of lipids, fatty acids, 
phospholipids, and sterols that are the building blocks of new cells[11]. There is no definitive answer 
as to how Etn affects the cell in order to induce apoptosis. Therefore, it was of interest to see 
whether Etn treatment affected lipid reservoirs in the cells. The combination of ORO staining and 
image analysis with ImageJ would allow for the visualization of any possible changes within the 
cytoplasmic content of LDs between Etn treated and control cultures.   
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2.2 Aim 1 Objectives 
• Validate cancer cell model by identifying LDs in cancer cell line PC3-luc 
• Visualize morphological changes between treated and untreated cells (shape, size, LD 
number, etc) 
• Use software to digitally quantify relative amount of lipids in each sample 
 
2.3 Hypothesis 
Due to its anticancer properties, the use of exogenous Etn should have a visible physical 
impact on the morphology of the PC3 cell line. Previous studies in the Aneja lab have shown that 
treatment with Etn causes the reduction of certain phospholipids within the cell, including 
phosphatidyl choline, sphingomyelin, phosphatidyl serine and phosphatidyl ethanolamine. All 
these are present within the monolayer of the LDs[19]. Therefore, Etn’s use on cancer cells should 
affect LDs by either distorting their surface to volume ratio or the disruption of their protective 
phospholipid monolayer.  
 
2.4 Materials and Methods 
 
Figure 2.4.1 Schematic overview of methodology used in Aim 1 
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2.4.1 Cell culture 
PC-3-luc cells (Perkin Elmer) were cultured in complete media containing 10% fetal 
bovine serum (FBS, GE Health) and 1% penicillin-streptomycin (Pen-Strep, Corning), under 
normal culturing conditions (37 °C, 5% CO2).  
 
2.4.2 Oil Red-O staining 
Oil Red-O staining (Sigma, cat #O-0625) was done on control and 2mg/mL Etn-treated 
PC-3-luc cells cultured in 35 mm Petri dishes. Plates were then incubated under normal conditions, 
and taken down in matched pairs at 1, 4, 8, 16, and 24 hrs. At each timepoint, cells were fixed in 
place with 4% paraformaldehyde for fifteen minutes and washed with phosphate buffered saline 
(PBS). Samples were washed with 60% isopropyl alcohol and stained with Oil Red-O dye (5 mM, 
5 mins) before washing under tap water until solution ran clear. Dishes were counterstained with 
Harris’ hematoxylin solution (Sigma, cat # HHS16, 1 min) and washed as before. Coverslips were 
mounted with glycerol and dishes were kept in the refrigerator until imaging.  
 
2.4.3 Oil Red-O imaging and analysis  
Fixed, stained dishes were imaged on a Zeiss Axio A-100 microscope with a 100x 
magnification, oil-immersion objective. 10-15 images (Axio 2 Imager 2 LED camera) were taken 
per timepoint, per group for densitometry analysis. Images were color thresholded on ImageJ 
software, to select all red pigmentation, and measured relative to the amount of space occupied by 
cells in each FOV. Percent of staining was calculated as follows: 
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Figure 2.4.2 Selection of LDs and cell body for ImageJ analysis 
 
Percent of staining was calculated as follows: 
 %Oil Red-O staining= 
𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑂𝑅𝑂 𝑠𝑡𝑎𝑖𝑛𝑖𝑛𝑔 𝑎𝑟𝑒𝑎
𝑇𝑜𝑡𝑎𝑙 𝑜𝑐𝑐𝑢𝑝𝑖𝑒𝑑 𝑎𝑟𝑒𝑎
  X 100 
Measurements of each group, per timepoint were compared via ANOVA with Tukey’s. P-
values were determined with unpaired t-tests.  
 
2.5 Results  
PC3 cells have been characterized and in use for the purpose of drug research since their 
development in 1979. As their other cancerous relatives, they contain LDs that allow them to thrive 
in their environment by providing energy and structural components for rapid proliferation. These 
LDs could be targeted as part of an anticancer therapeutic. Given Etn’s proven effectiveness 
against several cancer cell lines, including PC3, the purpose of this study was to observe its effect, 
if any, on the LD population within the cell and quantify that effect using digital analysis 
techniques.  
In cell samples treated with Etn, there were a few notable morphological changes when 
compared to the control. These cells are epithelial-like in shape, and so, they extend out their 
cytoplasm to increase their available surface area for nutrient exchange. Within the first three time 
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points (1, 4 and 8 hrs) there appears to be cell rounding in the treated group (Figure 2.5.1 F-H) 
when compared to the control group at the same time points (Figure 2.5.1 A-C). This cell rounding 
comes accompanied with the loss of definition of the borders of the cell’s cytoplasm, suggesting a 
weakening, loss of elasticity or adverse effects to cell adhesion properties of the cytoplasmic 
membrane in the presence of Etn. Additionally, vacuole-like structures are present in the cytoplasm 
of treated cells that are not present in the control group (black arrow heads). In general, there is a 
visible reduction of LD content in treated cells as compared to their respective controls.  
Densitometry analysis of ORO staining required the relative amounts of red in the image, 
known as “positive ORO staining area” be ratiometrically compared to the total area of the FOV 
that was occupied, or “total occupied area”, as previously described in the methods. ORO staining 
comparison between control and treated groups resulted in the significant decrease of positive red 
staining in treated groups (Figure 2.5.1 K) for the first four time points. This reduction correlates 
with the visual decrease of LDs seen in panels A-J.  
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Figure 2.5.1 Oil Red-O Quantification of stained PC3 cells at various timepoints. 
Representative images of monolayer culture of PC3 cells under control (A-E) and treated (F-J) at 
all time points. Quantification of positive Oil Red-O staining (K) uncovered significant differences 
in lipid droplet content. Treated cells (gray bars) show a significant decrease in positive Oil Red-
O staining at several time points when compared against control (black). Results seen as mean  
standard deviation. Scale bars = 5 m. Significant differences defined as * = p value < 0.05, ** 
= p value <0.01, *** =p value < 0.005, ****=p value < 0.0001.  
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2.6 Discussion 
LDs are a cell organelle found in most eukaryotic cells and are part of the cell’s dynamic 
lipid metabolism. In cancer cell lines, these LDs provide the energy and materials necessary for 
the cell to quickly divide and flourish in low-nutrient environment. The framework of this 
experiment sought to uncover whether the Etn’s mode of action involved, in part, the disruption 
of the cell’s lipid metabolism. Through the use of basic lab techniques such as cell culture, cell 
staining and microscopy, it was possible to visually compare the amount of positive lipid staining 
in PC3 cells under either normal growth medium conditions or Etn treatment.  
Gross visual analysis of the cell’s morphology revealed a change in cell shape of Etn treated 
groups at early time points in the form of filopodia retraction and cytoplasmic disruption. This 
caused the cells at earlier time points to appear rounded and vacuole-like structures in the 
cytoplasm in Etn-treated samples, characteristics not present in the control group. Additionally, 
the confines of the cell, as established by the cell membrane, did not exhibit the opaque or feathered 
edges seen in the treated group. Poorly defined borders might be a sign of cell membrane weakness 
brought on by treatment. Moreover, the number of LDs visible within the cell cytoplasm seemed 
to be reduced in the experimental group. This reduction might help explain the loss of cell 
membrane definition, as there are less sterols and lipids on hand to create the membrane, the cells 
make do with whatever materials present. Cell shape and LD number seemed to normalize by 24 
hrs.  
Images acquired for each of the samples were further analyzed through the software ImageJ. 
About 10-15 images per group, per time point were evaluated under the same hue, saturation and 
brightness thresholds in order to subjectively analyze LD density within cells. Quantitative 
analysis of ORO staining was concurrent with the gross analysis of images. Within the first four 
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time points (1, 4, 8 and 16 hrs.), there was significant decrease in LD density in the cytoplasm of 
Etn-treated cells than their control group counterparts. Much like the cell shape recovery, LD 
density also normalized within 24 hours of treatment. This can be due to the combination of the 
degradation of Etn in the media along with the fact that these cells undergo a division 
approximately every 23 hrs. Any Etn-resistant cells, which would have been unaffected by 
treatment, would have divided into a new generation on the plate, reestablishing the LD levels in 
the cytoplasm per FOV. 
 
2.7 Conclusion 
Etn is a small molecule with proven anticancer properties. While its mechanism of action 
is not entirely known, previous publications have linked its therapeutic use in cancer cells in the 
activation of several pathways that lead to cell death. The purpose of this study was to determine 
whether Etn activates pathways that disrupt the lipid metabolism by affecting change to the cell’s 
lipid reservoirs. Through staining, microscopy and digital analysis of acquired images, it was 
determined that Etn does, indeed, affect LD content in cell cytoplasm when compared to control 
population, at several time points. Although cell population recovers LD content at 24 hrs, Etn’s 
targeted impact on the LD population at early stages of treatment make it a strong candidate as a 
non-toxic, daily, oral anti-cancer regimen in order to maximize its effects. Additionally, Etn 
treatment brings about a change in general cell morphology. In conclusion, Etn causes a disruption 
in lipid metabolism that can be appreciated through low-cost computational methods. With these 
results in mind, the next step was to identify what signaling pathways related to apoptotic death 
were affected by this metabolism disruption.  
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3 AIM 2: SIGNALING CHANGES IN PC3 CELLS 
3.1 Introduction 
Calcium, in its ionic form Ca2+, is the most common signal transduction molecule in cells of all 
types[29] [30]. Ca2+ is essential for cell growth and survival, and due to the extent of its effects upon 
the cellular network, it is difficult to assign its effects to one universal mechanism. Intranuclear 
Ca2+ increases initiate gene expression and cell cycle progression, but also can activate degradative 
processes in programmed cell death[31]. This is due to the fact that prolonged high calcium 
concentration ([Ca2+]) activates nucleases that cleave DNA and degrade cell chromatin[31]. 
Therefore, the concentrations of Ca2+ inside and outside the cell have to be tightly regulated, lest 
they trigger the cell’s own demise.  
 Though required for normal cell functions, calcium cannot be metabolized in the same way 
other second-messengers are recycled[29]. Under normal physiological conditions, the 
concentration of intracellular calcium ([Ca2+]i) is approximately 100nM, which is about 20,000-
fold lower than the average [Ca2+] in the extracellular environment[29]. Increased [Ca2+] within the 
cell can cause toxicity and will eventually lead to cell death, which means that the cell has to 
develop mechanisms to chelate and store Ca2+ in an inert state to maintain stable [Ca2+]i
[29]. For 
this purpose, the cell employs two types of Ca2+ buffers, both mobile and immobile, that will trap 
and bind the ions in a secure formation until needed.  
From a molecular standpoint, Ca2+ ions are able to coordinate a large amount of oxygen 
atoms in their primary array spheres (4-12 atoms)[29] [32], though common coordination spheres 
arrange 6-8 oxygen atoms per calcium ion[32]. Specific calcium-binding proteins use this 
coordination to tightly sequester the ion through glutamate and aspartate residues that are charged 
at biologically relevant pH[29]. This sequestration acts as a Ca2+ buffer that increases in binding 
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capacity as intracellular calcium concentration increases[30]. The action of these buffers affect the 
rate of diffusion of calcium ions throughout the cell, making it one of the slowest diffusing ions[32]. 
These proteins can be suspended in solution, acting as a mobile buffer, and in smaller cells, they 
are sufficient to control [Ca2+][29].  
In eukaryotic mammalian cells, however, increased cell size means that the use of mobile 
buffers alone is not sufficient to regulate the concentration of Ca2+ within the cytoplasm[29]. In this 
case, the use of immobile buffers, in the form organelles with the capability to trap and store the 
ions within their confines, are employed[31]. The biggest intracellular Ca2+ store is the endoplasmic 
reticulum (ER). The ER is a large three-dimensional network of membranes that is employed in 
packing away materials into vacuoles. The ER acts as an anchor to Ca2+-binding proteins, and 
actively sequesters Ca2+ into the intraorganellar space[30]. Specialized ATP-dependent pumps, 
known as the smooth ER calcium (SERCA) pumps move Ca2+ from the cytoplasm into the ER 
where proteins, such as calsequestrin, bind the calcium in a dynamic storage, to be released only 
under certain signals have been received to deliver Ca2+ to the cytosol[29].  
 There are different mechanisms to slightly increase [Ca2+] in the cytosol. Ions from the 
extracellular environment and the ER are transported into the cytosol across the plasma membrane 
or from the ER through ion channels, respectively[29]. In non-excitable cells, such as cancer cells, 
the inositol (1,4,5)-triphosphate (IP3) pathway predominates in calcium signaling
[33] [34]. Both G 
protein-coupled receptors (GCRs) and receptor tyrosine kinases (RTKs) release IP3
[29]
 
[33]. GCRs 
activate phospholipase C, while RTKs stimulate phospholipase C to convert 
phosphatidylinositol (4,5)-bisphosphate into IP3 and diacylglycerol
[29] [31] [33] [34]. IP3 acts as an 
intracellular second messenger that triggers the release of Ca2+ from the ER by binding to its 
receptor in the ER[33]. This Ca2+ release can increase [Ca2+]i from 100 nM to almost 1M[29]. For 
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Ca2+ to enter cells by crossing the plasma membrane, the membrane must be depolarized[35]. Open 
potassium channels force the membrane potential to more negative potentials, drawing Ca2+ more 
rapidly across the plasma membrane[29] [36]. Ca2+ then enters through voltage-independent Ca2+-
specific ion channels[29].  
 The ER is not the only organelle that acts as an immobile buffer for Ca2+. Mitochondria 
accumulate Ca2+ at up to 0.5mM levels in the mitochondrial matrix owing to a large 
electrochemical gradient by mitochondrial hydrogen exchange (H)[31] [37]. Avoiding 
mitochondrial Ca2+ overload is energetically demanding for the cell, which has evolved a number 
of transport mechanisms to control energy expenditure[31]. Ca2+ concentrations in the 
mitochondrial matrix are controlled by a balance of influx and efflux pathways. Mitochondrial 
Ca2+ uniporters (MCU) control the influx of the ion. They have lower affinities for Ca2+ than 
SERCA pumps and are only significant when cytosolic Ca2+ rises above ~0.5M, activated by 
external Ca2+ and the allosteric effect of adenine nucleotides[31] [38]. Efflux is controlled by Na+-H+ 
or Ca2+-Na+ exchangers. Some studies suggest that the mitochondria’s sensitivity to the release of 
Ca2+ from the ER means that there are close contacts between both organelles that are involved in 
molecular crosstalk[31].  
Reactions within the mitochondrial matrix lead to the synthesis of several molecules, 
including nucleotide precursors and fatty acids that give rise to phospholipids[31]. In tandem, the 
mitochondria play a role in the homeostasis of Ca2+ within the cell, giving rise to effectors that can 
link calcium fluctuation to changes in energy metabolism[39]. Substantial evidence has built up in 
recent years indicating that metabolic regulation is only one of the roles of the mitochondrial Ca2+ 
signal[31]. In particular, the role of mitochondrial Ca2+ reserves in the intrinsic cellular signaling 
for triggering cell death is well established[39] [40].  
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In order to induce apoptosis, early cell death events must induce the release of cytochrome 
c from the mitochondria and Ca2+ from the ER into the cytosol[29] [31] [40]. The release of cytochrome 
c from a small subset of mitochondria will activate the IP3 pathway, therefore releasing Ca
2+ from 
the ER into the cytoplasm[30]. This will create a feedback loop that will drive the release of 
cytochrome c from the majority of the cell’s mitochondria, forming the apoptosome and leading 
to caspase activation, eventually triggering cell death[29] [31] [40]. The mitochondrial pathway of 
apoptosis is regulated by members of the Bcl-2 protein family, including: Bcl-2, and Bax and Bak, 
acting as anti- and pro-apoptotic proteins, respectively[31].  In cells that circumvent programmed 
cell death, like cancer cells, Bcl-2 has been shown to act in Ca2+-storing organelle membranes, 
such as ER and mitochondria to reduce the steady-state [Ca2+] ([Ca2+]SS) in the ER to diminish the 
effect of the apoptotic signal[31] [36].  
In order to avoid accidentally triggering cell death, [Ca2+]SS must be maintained through a 
delicate balance of calcium influx to the cytosol and efflux to the extracellular space or ER[29]. 
Certain conditions involve cells foregoing the process of programmed cell death once the unit 
reaches senescence, prompting scientists to find tools to trigger apoptosis and get rid of the 
abnormal cell[31]. Among these tools live-cell imaging has become a widely recognized resource 
to track fluctuations in Ca2+ release and changes in mitochondrial polarization. The use of 
fluorescent tags, sensitive to these two factors are able to give qualitative and quantitative 
comparisons of control and treated cells to determine treatment effectiveness.  
Fura-2-acetoxymethyl ester (Fura-2AM) is a membrane-permeant ratiometric dye that 
measures [Ca2+] by fluorescence[41]. Once the dye is incorporated into the cell cytosol, cytosolic 
and organelle esterases convert the acetoxymethyl ester (AM) forms into Ca2+-sensitive carboxylic 
forms[41]. This Ca2+-induced fluorescence has maximum emission at 340 and 380 nm[41]. Excitation 
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at these wavelengths results in differences in emission intensities, the ratio of which is used to 
determine the [Ca2+]i
[41]
. The use of a fluorescent ratio allows for the normalization of variables of 
cell thickness or dye concentration that may lead to false results, making it a robust measurement 
for intracellular Ca2+. 
Tetramethylrhodamine ethyl ester (TMRE) is a rhodamine-derived fluorescent dye known 
as a “redistribution dye”[42] [37]. This dye is able to cross the plasma membrane into the cytosol 
where its lipophilic character, charge and solubility allows it to accumulate within the inner 
mitochondrial membrane space[42].  The distribution of the free dye across the inner membrane of 
the mitochondria follows the Nernst equation, where its uptake is dependent upon electrical 
potential across the membrane ()[42] [37]. The flux of Ca2+ across the mitochondrial membrane 
can cause changes in  due to the ion’s poor electronegative exchange potential compared to 
traditionally used H+[29]. TMRE can be used as a qualitative assessment of tandem signaling 
pathways affection both normal Ca2+ signaling and mitochondrial function as a response to an 
external stimulus. 
The use of exogenous Etn has been shown to cause cell death in different cancer cell lines, 
including PC3. Etn-treated cells expressed higher levels of pro-apoptotic markers and a decrease 
of anti-apoptotic markers that are classically Ca2+-sensitive[19]. Therefore, it was of interest to 
evaluate if Etn’s effectiveness was in any way related to the activation of Ca2+ apoptosis pathways 
in the ER and mitochondria. In order to test this, the use of live cell imaging using Ca2+- and -
sensitive dyes (Fura-2AM and TMRE, respectively) was employed with healthy PC3 cells to track 
Ca2+ and  fluctuations before and after Etn treatment. In the case of fura-2AM imaging, the 
measurements were taken in both Ca2+-rich and -depleted conditions. Measurements were taken 
in both conditions as a manner to pinpoint the source of Ca2+ leaks into the cytosol. If the 
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environment in which the cells are contained lacks Ca2+ sources, it would stand to reason that Ca2+ 
entering the cytosol comes from intracellular stores, such as the ER or mitochondria.  
 
3.2 Objectives 
• Track changes in Ca2+ signaling of healthy cells following Etn 
• Ca2+ influx versus Ca2+ release from internal stores  
• Determine the effect of Etn on mitochondrial membrane potential 
 
3.3 Hypothesis 
Ca2+ is the most common signal transducer in the cell, impacting the function and integrity 
of all organelles, including the ER, nucleus and mitochondria. Previous studies in the Aneja lab 
have reported the positive effect of Etn in the increase and decrease of pro-apoptotic and anti-
apoptotic markers, respectively. Among the affected markers Bax and Bcl-2, Ca2+-sensitive 
mitochondrial proteins, were present. Therefore, we hypothesized that Etn induces cell death 
through Ca2+-dependent pathways involving the activation of caspase through the mitochondria. 
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3.4 Materials and Methods 
 
Figure 3.4.1 Schematic representation of methodology used for Aim 2 
 
3.4.1 DIC Imaging 
An Olympus microscope equipped with the water-immersive objective (40X), DIC filters, 
and acquisition and offline analysis software (Till Photonics, FEI, Germany) were used for 
acquiring DIC time-lapse images of PC3 cells and their lipid droplets. 
 
3.4.2 Live cell ratiometric intracellular Ca2+ imaging.  
An Olympus microscope equipped with the water-immersive objective (40X), ratiometric 
dichroic mirror with 340/380 split, 400 nm long-pass emission filter and acquisition and offline 
analysis software (Till Photonics, FEI, Germany) were used for acquiring ratiometric time-lapse 
images of fura 2 fluorescence in the cytoplasm of PC3 cells.  
Cells were loaded with 5 M fura-2 AM (Molecular Probes, Eugene, OR, USA) for 30 min 
at 37C, washed 3 times with the extracellular solution (see pharmacological agents) and incubated 
for another 20 min at 37C. Acquisition and analysis of calcium images were conducted using Live 
Acquisition and Offline Analysis software (Till Photonics, FEI, Germany). Time-lapse images 
were acquired every 30 min after 100 ms exposure at 340 nm and 380 nm excitation light and 420 
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nm long-path emission filter. The ratio of emission fluorescence intensities at 340nm excitation to 
380nm excitation was used to assess changes in intracellular calcium concentration. PC3 cells were 
excluded from analysis if their pretreatment ratios of [Ca2+]i, exceeded 0.7, which indicated a 
calcium concentration above normal resting cytosolic values of calcium, as established in earlier 
experiments [43]. 
 
3.4.3 Live cell mitochondrial potential imaging 
Cells were incubated with tetramethylrhodamine, ethyl ester (TMRE) (Molecular Probes, 
Eugene, OR, USA), the mitochondrial potential dye for 30 mins at 37C, and subsequently washed 
three times. Cells were observed on an Olympus fluorescent microscope, equipped for live imaging 
using a 40x magnification, water immersion objective and Live Acquisition software. Images were 
acquired using 535 nm excitation and a long path 590 nm emission filter. Time-lapse images were 
acquired every 30 seconds. The intensity of fluorescence was measure in the region of interest 
(ROI) that included one or a few mitochondria. Baseline measurements for mitochondrial potential 
were taken as a control before adding Etn to a final concentration of 2mg/mL. Mitochondrial 
polarization was then tracked for an additional 20 mins.  
 
3.5 Results 
Live cells imaging provides information in real-time of cellular responses to external 
stimuli, such as drug treatments. In this study, the fluctuations in [Ca2+]i and  were evaluated 
using fura-2am and TMRE fluorescent dyes, respectively. Ca2+ was measured in conditions in 
which external Ca2+ was and was not readily available (Figure 3.5.1). While using fura-2AM dye, 
a fluorescence intensity ratio baseline was taken on healthy cells within the ROI. This baseline 
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was 0.50 and 0.37 in Ca2+-containing (black line) and non Ca2+-containing media (grey line), 
respectively. Following baseline reading and normalization, Etn was added dropwise into the 
observation dish to a concentration of 2mg/mL (red arrow). A solvent control was used to discard 
the possibility of fluctuations due to addition solution to the observation dish. Increase in 
fluorescent ratio was observable within the first 30s (first measurement following treatment), 
reaching its peak at around 2 mins in Ca2+-containing media and 3 mins in non-Ca2+-containing 
media. Once at its peak, fluorescent ratio normalized to near-baseline levels, indicating that Ca2+ 
increase was a transient event. Fluorescence was monitored for 30 minutes following Etn addition 
to capture any long-term effects. An extracellular solution-only control did not yield a response 
(Appendix A). 
In the case of  fluctuation using TMRE dye, a fluorescence baseline of healthy cells 
within the ROI was similarly acquired (Figure 3.5.2). Etn was added dropwise into the observation 
dish (red arrow) to a concentration of 2mg/mL. Within 2 mins of treatment there was a 15% 
increase in fluorescent intensity that is immediately followed by a sustained decrease of signal. 
This increase and subsequent decrease correspond to a moment of hyper- and depolarization of the 
mitochondria, respectively. Fluorescence was monitored for approximately 30 minutes following 
treatment to capture any long-term effects. An extracellular solution-only control did not yield a 
response (Appendix A). 
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Figure 3.5.1 Calcium-dependent fluorescence in PC3 cells before and after Etn treatment.  
Black line denotes experiment done in solution containing 2 mM Ca2+ present. Gray line 
denotes experiment done in solution with no added Ca2+ and EDTA present as a Ca2+ chelator. In 
both cases, transient increases in calcium signaling followed the addition of Etn. Results shown 
as mean  SEM Graphs are average of n=5 ROI, N=3. 
 
Figure 3.5.2 Mitochondrial potential of PC3 cells before and after Etn treatment.  
Moment of hyperpolarization, followed by sustained depolarization resulted from the addition of 
Etn to observation plate. Results shown as mean  SEM. Graphs are average of n=5 ROI, N=3. 
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3.6 Discussion 
The traffic of calcium ions through multiple calcium channels are responsible for a plethora 
of cellular responses necessary for normal cell function. Previous data collected in the lab led to 
the question of whether Ca2+ mediated pathways were responsible to the induction of cell death of 
PC3 cells following treatment with Etn. Fura-2AM, was used to measure [Ca2+]i, Its ratiometric 
property allows imaging software to calculate an accurate fluorescence by comparing the intensity 
of emission at 340 and 380 nm in order to accurately calculate [Ca2+]i. Measurements were 
recorded in conditions where extracellular calcium was and was not available ([Ca2+]ex = 0),.  In 
both cases, a transient increase in calcium signaling can be observed approximately 2 minutes 
following Etn treatment (Figure 3.2).  
The rates of transient Ca2+ increase differ depending on whether or not there are external 
sources of Ca2+. The sharp rise of the intensity of fluorescence in Ca2+-rich conditions compared 
to slower rise in Ca2+-free conditions is indicative of Ca2+ influx from the extracellular 
environment in order to replenish the Ca2+ stores within the cell or the depolarization of the plasma 
membrane, opening the voltage-gated Ca2+ channels and allowing ions to the cytosol. This 
transient increase in [Ca2+]i, that was independent on the presence of extracellular calcium suggests 
Etn-induced calcium release from intracellular stores. This increase in [Ca2+]i, in turn, can affect 
the polarization of the mitochondrial membrane, leading to the activation of  [Ca2+]i,-mediated cell 
death pathways through the release of cytochrome c [31] [30].  
Following transient Ca2+ increase in both conditions, baseline fluorescence did not return 
to control levels. This difference may be attributed to the availability of Ca2+ in the environment 
and the tight regulation of Ca2+ homeostasis in the cytosol. In conditions where Ca2+ is available 
in the extracellular matrix, the cell must work to sequester ions released from organellar stores to 
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maintain normal [Ca2+]i (100nM). The opposite is true for cells that were observed in [Ca
2+]e=0. 
A Ca2+ chelator is added to the solution to guarantee a near zero and insignificant concentration of 
Ca2+ in the extracellular environment, leaving Ca2+ leaked out of the plasma membrane to become 
unavailable for re-entry. This may cause the cell to prevent further sequestering into the ER or 
mitochondria until a point in time where exchange between intracellular and extracellular Ca2+ 
sources, as it occurs normally, can be re-established. Perhaps a longer observation of cells in both 
conditions see the fluorescence returning to control baseline levels.  
Having established a change in [Ca2+]i following Etn treatment, it was of importance to 
review the impact of this change on the cell’s mitochondria. The compounding of changes in 
mitochondrial potential and [Ca2+]i could point towards the triggering of Ca
2+-mediated cell death 
pathways as the source of Etn’s effectiveness. A fluorescent polarization marker, 
tetramethylrhodamine, ethyl ester (TMRE), was employed alongside live cells imaging to track 
changes in . The addition of Etn led to a brief hyperpolarization period, followed by a sustained 
depolarization of the mitochondria (Figure 3.5.2) around the same time in which changes in [Ca2+]i 
occur. It may be possible that the Ca2+ release from the mitochondria initiates the release of Ca2+ 
from ER, causing the initial hyperpolarization before going into sustained depolarization.  
Previously, our lab has shown that treatment of PC3 cells with Etn led to a decrease of Bax 
and an increase in Bcl-2 expression, all necessary for the initiation of apoptosis. In order to 
substantiate these assumptions, further experiments on the effect of intracellular Ca2+ stores in the 
process of apoptosis are required. The idea behind this would be to determine whether the 
emptying of intracellular Ca2+ stores, such as the ER and mitochondria prior to Etn treatment will 
delay apoptosis. If so, then the conjunction of these results points towards Ca2+-aided initiation of 
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apoptosis signaling cascade due to the activation of Bax, the decrease of Bcl-2 and the release of 
cytochrome c from the mitochondria. 
 
3.7 Conclusion 
The effects of Ca2+ changes within the cell activate a diverse range of pathways necessary 
for normal cell growth, function and the initiation of programmed cell death. The effects of calcium 
signaling are widespread and can involve different organelles, including the ER and the 
mitochondria. Transient increases in [Ca2+]i can induce the formation of the apoptosome by the 
activation of apoptotic markers and the release of cytochrome c from the mitochondria due to 
changes in mitochondrial membrane potential. Etn causes the transient increase of Ca2+ in the 
cytosol of healthy cells through the depletion of intracellular calcium stores and import of Ca2+ 
from the extracellular environment. This depletion of intracellular stores accompanies a 
simultaneous dysregulation of . Taking these results into consideration with previous data of 
Etn decreasing the activity of anti-apoptotic markers and increasing the activity of pro-apoptotic 
markers we can conclude that part of Etn’s effectiveness comes from the activation of Ca2+-
dependent apoptotic pathways. This increase in intracellular Ca2+ may also be the trigger of Ca2+-
dependent hormone stimulated lipolysis. Measurement of the rate of lipolysis with and without the 
emptying of ER Ca2+ stores prior to treating with Etn would conclusively link the transient Ca2+ 
increase with the changes in LD content seen in Aim 1.  
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4 AIM 3: IDENTIFICATION OF KEY PLAYERS IN LIPID METABOLISM-
RELATED CELL DEATH 
4.1 Introduction 
Lipids are an essential macromolecule for healthy cell function[10] [9]. They comprise of a group of 
hydrophobic molecules that include triacylglycerides (TAGs), sterols, sphingolipids, and 
phospholipids  and are necessary at a cellular level for energy storage and structural purposes[9]. 
Fatty acids (FA) are the building blocks for TAGs, part of lipids that are stored within LD stores, 
whereas phospholipids, sterols and sphingolipids are the major components of all biological 
membranes[9] [44]. In addition to energy and structure, lipids can have roles in cell signaling, some 
working as second messengers and hormones for the purpose of communication between cells[9]. 
It has been established that lipid metabolism within cancer cells greatly differs from the 
metabolism of “normal” healthy tissue[10] [9] [44] [45] [46]. These changes can affect cell growth rate, 
proliferation, differentiation and motility[45].  
 Most eukaryotic mammalian cells import their lipids from the extracellular environment, 
rather than making their own[10] [9]. FA and lipoproteins are synthesized in the liver or adipocytes 
from the breakdown of carbohydrates. These molecules enter circulation and are taken up by cells 
to use as energy or to store them in the form of LDs[9] [44]. Fetal and undifferentiated cells possess 
the ability to create their own lipids in a process known as de novo lipogenesis[10]. However, once 
cells differentiate into mature cells, only a handful of cell types, including liver, adipose and 
lactating breast tissue, retain this ability[10].  
In order to make FA, cells use acetyl groups provided by citrate from the tricarboxylic acid 
cycle (TCA) and convert it into acetyl-coenzyme A (acetyl-CoA) and oxaloacetate in an adenine 
triphosphate (ATP)-dependent reaction[9] [10] [45]. Oxaloacetate is then converted into pyruvate and 
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nicotinamide adenine dinucleotide phosphate (NADPH), which is used in the pentose phosphate 
pathway to make lipids[10] [9]. Acetyl-CoA is transformed to malonyl-CoA in an enzyme-catalyzed 
reaction, subsequently acetyl and malonyl groups are coupled to the fatty-acid synthetase 
enzyme[10] [9]. The condensation of acetyl groups generates a 16-carbon saturated FA known as 
palmitic acid[10] [9]. This FA is elongated and desaturated in the cytoplasmic face of the ER 
membrane[10] [9]. Desaturation alters the newly-synthesized FA’s physical properties in order to 
create species suitable for either plasma membrane creation (sphingolipids, phospholipids) or 
energy storage (triacylglycerides)[10] [9].  
Another important process within lipid metabolism is the mevalonate pathway, from which 
cholesterol is synthesized[9] [45]. This process involves the condensation of acetyl-CoA with 
acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA)[9] [45]. The reduction of 
HMG-CoA to mevalonate by HMG-CoA reductase represents the rate-limiting reaction of this 
pathway and is highly regulated[9] [45]. Cholesterol is an important component of cell membranes, 
responsible for modulating the fluidity of the bilayer and forming detergent-resistant 
microdomains called lipid rafts that can also be used as signal transducers[9] [45] [44]. Additionally, 
sterols form the backbone of hormones, and so, are important in their synthesis. Previous studies 
have identified the accumulation of cholesterol as a hallmark of prostate cancer[45].  
Cancer cells are characterized by proliferation rates that are faster than their healthy 
counterparts[10] [9] [45] [46]. This high proliferation rate requires large amounts of lipids in order to 
create new membranes[10] [9] [45] [46]. Scientists discovered long ago that cancerous tissues possess 
the ability to undergo de novo lipogenesis in a manner similar to embryonic tissue[10]. Some 
cancers, like breast and prostate, are characterized by an increased expression of fatty acid 
synthetase (FASN), which suggests that fatty acid synthesis is an important part of pathogenesis[10] 
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[9] [44]. However, the source of these FAs may determine the phospholipid composition of the 
membranes due to the cell’s limited ability to synthesize polyunsaturated FAs de novo, as they do 
not possess the enzyme  12 desaturase[44]. This means that cancer cell membranes are enriched 
with a mixture of saturated and monounsaturated FAs, which are less prone to lipid peroxidation, 
and, therefore, more resistant to oxidative stress-induced cell death[9] [44]. Saturated lipids are more 
densely packed, which alters membrane dynamics that limit uptake of materials from the 
extracellular environment, such as drugs, which poses a problem with targeted therapies[9] [44].  
Most cancer cells exhibit an increased consumption of glucose, which they break down 
through the glycolytic pathway to create lactate, regardless of the availability of oxygen, a 
phenomenon known as the ‘Warburg Effect’[44] [10]. It is possible, however, to break down FAs for 
energy through a process called -oxidation[44] [9]. In this process, cytoplasmic free-FAs are 
coupled to CoA and transferred to carnitine by the enzyme carnitine acyltransferase and shipped 
into the mitochondrial matrix[44] [9]. After entering the mitochondria, the acyl chains are recoupled 
to CoA, where it undergoes several steps of oxidation and hydration, yielding NADH and flavin 
adenine dinucleotide (FADH2), as well as acetyl-CoA that can enter the tricarboxylic acid (TCA) 
cycle[44] [9]. In the case of prostate cancer, tumors exhibit low rates of glucose consumption, 
increased FA uptake, and an increased dependence on -oxidation of FAs as their main source of 
energy[44] [9]. Additionally, prostate cancers have been shown to overexpress certain markers, such 
as elongases leading to the production of very long FA chains that may play a role in cancer 
transformation[44] [9] [10]. 
Different cancer cell types have different preferences as to where they mainly source their 
FA[44]. Although, it is generally acknowledged that de novo lipogenesis is an active pathway, it is 
possible to use exogenous FAs to substitute endogenously made FAs[44]. Therefore, the majority 
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of cancer cell types maintain a balance of both lipogenic and lipolytic pathways to fill their FA 
needs, depending on their environment, in order to ensure survival. [44] For example, aggressive 
breast cancers that lack normal markers, known as triple-negative breast cancer, express a 
lipoprotein lipase, which is capable of breaking down extracellular lipids and use transmembrane 
mechanisms to incorporate the free-FAs created[44] [9] [10]. Regardless of where the FAs originate, 
however, excess materials (both FA and sterols) are stored within LDs in the cell cytoplasm[9] [44]. 
Stored FAs can be unpacked and transported for energy generation through a series of lipases, 
among them, hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATL), and 
monoacylglycerol lipase (MAGL)[44] [9] [10].  
Intracellular lipolysis catalyzes the breakdown of FA necessary for proliferation, growth 
and cancer cell migration[44] [9] [10]. This lipolysis is promoted by lipases that de-esterify contents 
of LDs and create free-FA and glycerol in a process called lipophagy and is used by cells to adapt 
to stress and prolong cell survival[9] [44]. In addition to providing resources and energy for the cell, 
lipolysis helps cells avoid toxicity through the accumulation of saturated FAs (such as palmitate) 
and subsequent triggering of apoptosis[9] [44]. This accumulation of saturated FAs serves as a 
feedback loop to inhibit further FA synthesis until the cells are in need of material to transform 
into energy[9] [44]. Thus, it is necessary for the processes of lipogenesis and lipolysis to be balanced 
within the cell in order to maintain lipid homeostasis[44]. However, it is not known whether FAs 
obtained endogenously versus those acquired exogenously enter metabolic pathways for 
membrane and energy in equal measures, or whether one is preferred over the other for different 
applications.  
Calcium is known to be the effector of several different pathways within the cell, including 
those related to lipid metabolism[29] [30]. In studies involving adipocytes, it has been shown that 
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hormone-sensitive lipase activity was directly proportional to the amount of Ca2+ present in the 
system and that its effects could be ebbed through the introduction of a Ca2+ chelator, such as 
EDTA[47] [48] [49]. High [Ca2+]i activate cyclic adenylate monophosphate (cAMP) levels, either 
directly (through Ca2+ and/or calmodulin, CaM) or indirectly (through CaM kinase or protein 
kinase C) [50]. This increase in [cAMP], in turn, activates protein kinase A (PKA)[49] [50]. PKA is 
an enzyme used to phosphorylate other proteins within the cell[50]. In the case of LDs, PKA 
hyperphosphorylates perilipins, a family of proteins found on the surface of LDs and are meant to 
protect the LD from the action of lipases[49] [50]. Once phosphorylated, the perilipin changes 
conformation on the LD surface, allowing lipases, such as HSL, to degrade the neutral lipids within 
the LD[49] [50]. Although these mechanisms have been studied in adipocytes and hepatocytes it is 
likely that cancer cells follow a similar pathway due to their similarities in lipid metabolism. 
The ubiquity of Ca2+ makes it difficult to tease out the effects it has on observed 
pathways[29]. Although there are few tools for studying Ca2+ pumps, thapsigargin, a sesquiterpene 
lactone, irreversibly inhibits SERCA pump in a specific manner by trapping it in its Ca2+-free 
state[51] [52]. This means, that once the ER stores are emptied, and the [Ca2+]c is high, there is no 
way for the cell to pump the ion into the ER for sequestering[51] [52]. Thapsigargin provides a 
platform for comparison between Ca2+ store- and non-Ca2+store- stimulated cellular responses.  
In the previous aim it was established that the reduction of [Ca2+] within Ca2+ stores has 
protective effects toward a variety of inducers of cell death, such as ceramide and oxidative stress. 
Moreover, the introduction of this aim has talked about the differences in lipid metabolism between 
normal and cancerous cells, including the delicate balance between lipogenesis and lipolysis. Due 
to the results seen in previous experiments, it was of interest to determine whether the Etn-
stimulated disappearance of LDs within the model PC3 cells was due to increased lipolysis or the 
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inhibition of LD creation. In order to study this question, a colorimetric biochemical assay was 
used.  
During lipolysis TAGs are degraded into free-FAs and glycerol molecules that are exported 
from the cell cytoplasm into the extracellular environment[44] [9]. In order for the glycerol to be 
recycled, it must be phosphorylated in the liver to form glycerol-3-phosphate[10]. Due to the 
constraints of cell culture, once expelled from the cell, glycerol remains in solution within the 
media. The free glycerol assay uses an enzyme complex to phosphorylate and oxidize the glycerol 
from collected media which creates peroxide that reacts with the colorimetric probe. The saturation 
of the color probe (and, in so, the absorbance of the sample) is directly proportional to the amount 
of glycerol within the sample, yielding a robust, quantitative result that can be calculated in 
concentration against a standard curve.  
 
4.2 Objectives 
• Probe whether LD reduction comes as an effect of Etn-induced lipolysis 
• Evaluate whether there is a connection between the reduction in LD content seen in Aim 1 
with the transient increase in Ca2+ seen in Aim 2. 
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4.3 Hypothesis 
Enhanced or abnormal lipid metabolism is one of the hallmarks of cancer cells. Because 
these cells rely heavily on lipids and their metabolites to create energy and make the materials to 
aid in rapid proliferation, the destruction of LDs where these lipids are stored could prove to be an 
important therapeutic target. Data collected in the previous aims support the possibility of cells 
undergoing increased lipolysis due to Etn-treatment, as we see a decrease in LD presence in the 
cytoplasm, meaning a reduction of stored lipids, and a transient increase in Ca2+, which can induce 
many lipolytic pathways within the cell.  
 
4.4 Materials and Methods 
 
Figure 4.4.1 Schematic representation of methodology used in Aim 3. 
 
4.4.1 Lipolysis assay 
PC-3-luc cells were seeded at a density of 350,000 cells/mL onto 12-well plates, overnight. 
Control and 2mg/mL Etn-treated plates were incubated for 1, 4, 8, 16, and 24 hrs, wherein media 
was collected from the plates. Additional plates were seeded in a similar fashion and treated with 
100 nM Thapsigargin for 20 mins before being exposed to Etn for 1 hr. Positive controls (media 
only, Thapsigargin only) and negative controls (Etn only) were run alongside experimental group 
and collected in same manner. 
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Collected media was analyzed using the Free Glycerol Assay kit (Sigma), as per 
manufacturer’s instructions. Briefly, 10uL aliquots of the samples were pipetted into a 96-well 
plate and allowed to incubate at room temperature in the dark with active enzyme buffer and 
indicator for 10 minutes following moderate shaking. Plate was read on a UV-Vis 
Spectrophotometer (Molecular Devices) at 570 nm. Results were analyzed against a standard curve 
to determine glycerol concentration per sample. Results recorded as mean  standard deviation 
and analyzed using ANOVA with Tukey’s.  
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4.5 Results 
In a timed experiment, Etn treatment significantly increases the amount of glycerol released into 
the extracellular medium as early as 1 hr following treatment, normalizing by 24 hrs (A). These 
findings are consistent with ORO staining results seen in Figure 1. Cell samples pre-treated with 
thapsigargin, a SERCA pump inhibitor, release a lower amount of glycerol into extracellular 
environment following Etn treatment. Thapsigargin only control behaves similarly to media 
control (B).  Results in mean  standard deviation. p>0.05=*; p>0.01= **; p>0.005=***; 
p>0.001=****.  
 
 
Figure 4.4.1 Quantification of free glycerol in control (black) and treated (gray) cells as a 
measure of lipolysis. 
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Abnormal lipid metabolism is a critical part of cancer cell survival, proliferation and 
invasion, and any disruption in the processes involved could cause catastrophic effects. Therefore, 
we endeavored to evaluate whether there was any difference in lipolysis occurring within the cells 
following Etn treatment, and if there was any change in lipolysis rate through time. The amount 
of free glycerol in media was measured in control and Etn-treated cell culture wells as an indicator 
of lipolysis at five different time points (1, 4, 8, 16 and 24 hr). Spectrophotometric analysis of 
collected media presented with increased concentrations of free glycerol at 1, 4, 8, and 16 hours, 
normalizing to near-control levels by 24 hours (Figure 4.2A). Amount of glycerol in the media of 
the control group remained in an average of 0.040 0.002 mM throughout all time points. Cells 
treated with Etn released an average concentration of 0.101 0.015 at peak lipolysis 1 hr following 
treatment and steadily decreased to 0.039 0.003mM, 24 hrs after.  
Seeing as there was a more than two-fold increase in free glycerol within the media in Etn-
treated samples as compared to control samples, it was imperative to investigate whether this 
lipolysis was driven by a Ca2+-dependent mechanism. Two groups were pre-treated with the 
SERCA pump inhibitor, thapsigargin, before either being treated with Etn or used as a control, in 
addition to the original control and treated groups. Cells underwent Etn treatment for 1 hr, as this 
is foreseeably the longest the cell can withstand without incurring in significant stress due to lack 
of Ca2+. At 1 hr of treatment, there was no difference between media and thapsigargin control 
samples. Although both thapsigargin-Etn and Etn-treated cells had a significant increase in 
glycerol compared to control (0.060 0.011, 0.085 0.002, 0.040 0.002 mM, respectively), cells 
that were pre-treated with thapsigargin contained approximately 30% less glycerol in the media in 
comparison to its Etn-only counterpart (Figure 4.2B), suggesting that Ca release from intracellular 
stores (or a functional ER) is necessary for part of the effect of Etn on lipolysis.  
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4.6 Discussion 
Cancer cells thrive under a delicate balance of lipogenesis and lipolysis that allows them 
to grow, proliferate and invade healthy tissue at an accelerated rate[44]. They are able to utilize 
lipids as energy sources, building materials and signaling molecules to direct their growth in order 
to thrive in the microenvironment they are to inhabit[46]. These responses depend on the activation 
of different pathways that will evaluate their need to store or utilize synthesized or imported lipids 
at any given time. The relationship between calcium and lipolysis has been thoroughly studied in 
the context of adipose tissue. Intracellular calcium can modulate the rate at which lipids are broken 
down by the cell through the stimulation of several pathways, including the HSL pathway[47] [48]. 
The introduction of exogenous Etn to healthy PC3 cells has already been shown to have an 
effect on lipid stores in Aim 1. The marked decrease of positive LD staining was visible as soon 
as 1 hr following treatment and was not normalized to near-control levels until 24 hrs following 
initial treatment. Therefore, it was of importance to determine whether this significant decrease 
was due to the blocking of new LD formation following normal metabolism of lipids or, as 
hypothesized, the accelerated dismantling of LD structures in a process of increased lipolysis. 
Evaluation of free glycerol in the media of control and Etn-treated samples confirmed the increase 
of lipolysis within treated groups at 1, 4, 8, and 16 hrs following treatment, normalizing at 24 hrs 
(Figure 4.2 A). Knowing that increased lipolysis was occurring within treated cells, it was critical 
to determine whether this lipolysis was induced, whether totally or in part, through Ca2+-dependent 
pathways.  
Ca2+-dependent lipolysis, such as the hormone stimulated pathway (HSL), has been 
reported in lipid-rich cells, like adipocytes, as one of the major roadways to lipid homeostasis[50]. 
Due to the ubiquitous nature of Ca2+ in the cell it is difficult to claim that lipolysis seen in Figure 
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4.2 is due solely to the transient increase in Ca2+ seen in Aim 2. Utilizing a known Ca2+ pump 
inhibitor, thapsigargin, the rate of lipolysis was measured in thapsigargin-pre-treated groups 
against normal control and Etn-treated samples. The idea behind this experimental design was to 
deplete the cell’s internal Ca2+ stores and observe whether there was any difference to the lipolytic 
response once cells were treated with Etn. However, it was of utmost importance to maintain the 
time course of the experiment short, as to not stress the cell due to lack of intracellular Ca2+ reserves 
and the implications that a low Ca2+ availability could have on essential processes. Interestingly, 
while the cells pre-treated with thapsigargin before Etn exhibited increased lipolytic activity as 
compared to control samples, there was a marked decrease in lipolysis when compared to the Etn-
only group. Media-only and thapsigargin-only controls had similar rates of lipolysis (Figure 4.2 
B). This data suggests that Ca2+ is paramount for the activation of lipolysis. 
Though it is possible that Ca2+ is not the only second messenger that is participating or 
responsible for this response, this data supports the proposed role of Ca2+i in the activation Etn-
induced lipolysis. The HSL pathway, as described before, involves cation exchange from Ca2+-
binding proteins and the phosphorylation and several enzymes prior to the eventual esterification 
and degradation of LDs. This signaling cascade means the alteration of molecular charges and 
protein structure of many, if not all, the players involved[49] [50]. Therefore, it is possible that these 
changes can be observed through a high-resolution, vibration-based technique, such as Raman, 
photoacoustic or Infrared spectroscopy. The analysis of control and treated samples through these 
methods may yield information about protein sidechain coordination, such as electronegativity 
fluctuations between bonds, that will correlate to the known steps of the HSL pathways.  
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4.7 Conclusion 
In order to ensure that cancer cells have the resources necessary for rapid growth and 
proliferation there must be a balance between the processes of lipogenesis and lipolysis. Changes 
within calcium and mitochondrial signaling can affect downstream processes, such as the 
activation of lipolytic pathways, led by calcium-sensitive species[12] [14] [15]. Previous aims have 
demonstrated a reduction in LD content within the cytoplasm (Aim 1) and a transient Ca2+ increase 
(Aim 2) following Etn treatment. Therefore, it was important to look at lipolysis in the context of 
these two observations. The amount of free glycerol in the media was significantly increased in 
time points where a marked reduction of LD content was observed in Aim 1 (1, 4, 8, 16 hrs), 
confirming the claim that LD disappearance was due to Etn-induced lipolysis. Additionally, the 
introduction of a SERCA pump inhibitor, thapsigargin, as a pre-treatment led to decreased rates of 
lipolysis when compared to Etn-only groups. Hence, the Etn-induced state of lipolysis within PC3 
cells is due, in part, to Ca2+-mediated processes, such as the HSL pathway. The findings within 
this experiment allow for the exploration of the use of other Ca2+-channel agonists in the treatment 
of cancer. 
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5 AIM 4: MOLECULAR CHANGES IN PC3 CELLS 
5.1 Introduction 
The release of Ca2+ from intracellular stores into the cytoplasm is possible only due to the 
conformational change of proteins sequestering the ions, whether it be through oligomerization, 
phosphorylation or cationic exchange[29] [53]. Further than a physical alteration, this change in 
structure, along with the downstream effects of Ca2+ release (as is the inducement of lipolysis) has 
an impact on the overall molecular makeup of the cell[54]. These molecular changes are transient 
and cyclical in healthy cells, as the increase and decrease of [Ca2+] is tightly regulated in order to 
maintain homeostasis[29]. However, a sharp increase due to the administration of a drug can be 
distinguishable from normal metabolic patterns through high-sensitivity techniques.  
 Infrared spectroscopy (IR) is a one of the classic techniques for the study of small 
molecular structures[54] [55]. It is an integral part of biological research due to its large application 
range, high resolution, low acquisition time and small sample size requirement[54] [55]. The IR range 
of radiation (780 nm to 1mm wavelength) is absorbed by the electrons within a molecule[54] [55]. 
This radiation causes an excitation of the electrons, which in turn stimulates their vibration and 
oscillation in specific patterns known as transitions[54] [55]. The vibrational frequency depends on 
the strength and polarity of the vibrating bonds, making them susceptible to the intra- and inter-
molecular changes[54] [55]. The absorption bands will depend on both the type of bond (whether it 
is single, double or triple), the mass of atoms at either end of the bond, the electromagnetic pull of 
atoms donating or withdrawing electrons, from either within the molecule or those in the 
microenvironment[54] [55]. The strength of absorption has a proportional value to the increasing 
polarity of the molecule, meaning that all polar bonds can contribute to the IR spectra[54]. 
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 The IR spectra is represented in a plot as absorption as a function of the inverse of 
wavelength, or wavenumber (), with the unit cm-1[54]. Typically, wavenumbers run from high to 
low, from left to right, following the plotting convention for wavelength (small to large). The range 
in which IR radiation exists can be separated into three regions: i) near-IR, 780-2500 nm, ii) mid-
IR, 2500-50000 nm, iii) far-IR, 50000 – 106 nm. Mid-IR is the area most commonly observed 
when looking at biological systems, with wavenumbers ranging from 4000-200 cm-1[54] [55]. This 
is due to the fact that thermal energy at room temperature is approximately 200 cm-1, making mid-
IR the first level of vibrational excitation following ground level vibrational excitation[54]. 
 Modern IR spectroscopy is commonly Fourier Transform Infrared Spectroscopy (FT-IR). 
FT-IR possessed an interferometer with fixed and movable mirrors that generate a variable path 
between two beams that give the detector a signal[54] [55]. Light emitted by the source is split in 
two: one that is sent towards the detector and another that is reflected onto the moveable mirror 
and back towards the detector[54] [55]. When the beams combine destructive and constructive 
interference will occur, according to the wavelengths absorbed and emitted by the sample[54] [55]. 
The light intensity is relative to the optical path difference creates an interferogram in the form of 
a Fourier Transform[54] [55]. Another Fourier Transform done by the computer yields the spectrum 
that can be interpreted[54] [55]. The main advantage of FT-IR is that it is a method of rapid data 
collection and high light intensity the detector which responds with a high signal to noise ratio[55]. 
Samples can be analyzed either in transmission, transflection, or attenuated total 
reflectance (ATR) [54] [56] [57] [58]. Previously ATR was favored over transmission because it allowed 
a sample to be placed on a crystal without worrying about pathlength of the beam to the sample[54] 
[56]. IR light is directed towards the sample at an angle of incidence that is totally reflected at the 
interface of the sample and the scaffold where it rests[54]. This reflection incites the sample before 
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the light is reflected towards the detector to create the interferogram[54]. The sample could be 
mounted onto the slide to form a thin film with easily exchangeable buffer[54] [56] [57] [58]. Modern 
FT-IR spectrometers, however, are equipped for dry transmission analysis, and have been 
popularized by biological analysis[59] [60] [61]. Here, the sample (whole cell, protein sample or 
extract) is reconstituted in a small amount of buffer and placed upon BaCl2 slides and dried under 
a gentle vacuum in a nitrogen chamber[59] [60] [61]. This allows for whole structures to be analyzed 
in situ without any major damage to the sample[59] [60] [61].  
Though vibrational frequency changes due to changes in structure, it is impossible to 
determine structure of a molecule from IR spectra[54] [55] [61]. This is due to the fact that all polar 
bonds (bonds between atoms of different electronegativity) will create a band on the spectra, which 
can overlap and be difficult to deconvolute[54] [55]. However, it is possible to see changes, if any, 
in the structure through the migration, change of shape or intensity of specific IR bands[54] [55] [61] 
[62]. Vibration-based methods are so sensitive that they can detect changes as small as 0.002% in 
vibration due to the bond distortions arising from changes in bond length and strength[54].  
Additionally, vibrations in adjacent bonds of a molecule, like those that contribute to 3D 
structure, can affect each other[54]. As an example, changes in the amino acid side chains of proteins 
due to protonation or ion capture provoke the shift and disappearance of bands and is often used 
to measure enzymatic activity of certain proteins[54] [55] [57] [58] [61] [62]. A characteristic vibration 
that has been studied is the coupled carboxyl (COO-) vibrations of amino acid residues that act as 
cation chelators within the cell, as are the aspartate (Asp), glutamate (Glu) resides in the case of 
Ca2+ sequestration coordination[54] [29]. Some of the most commonly observed vibrational areas are 
depicted in Figure 5.1. In this figure, common vibrational modes of biologically abundant 
molecules are depicted (symmetric, asymmetric, scissoring, etc.) Each set of vibrations is also 
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associated to a macromolecule which are the more likely sources to the specific bands, and so, 
every vibration depicted is also color coded to correspond. 
 
Figure 5.1.1 Commonly observed FT-IR spectral regions in biological samples 
 
As discussed in the previous aims, the treatment of PC3 cells with Etn has yielded results 
in the form of the decrease of LD content within the cell cytoplasm, the transient alteration of 
[Ca2+]i, and the inducement of lipolysis through pathways involving Ca
2+ signaling. These 
responses are all consequences of molecular alterations taking place within the cell, interrupting 
normal functions and prompting its death. The hypothesis presented here has been that Etn’s effect 
is intrinsically linked to the changes in lipid metabolism via the disturbance of normal Ca2+ 
signaling. Etn causes a transient increase in Ca2+, promoting the activation of cAMP, and 
subsequent activation of PKA[50]. PKA will then hyper-phosphorylate perilipins on the surface of 
LDs, leaving space for HSL to unpack and degrade the LDs[50] [63] [64]. The neutral lipids within 
the LD are degraded into glycerol and FAs that get exported out of the cell to be recycled by other 
cells, or used for energy, respectively[50]. All of these alterations have an effect on the vibrational 
patterns of the cell’s molecules.  
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The loss of LD component stores, cation exchange from Ca2+-binding proteins, 
phosphorylation and 3D structure change of other proteins such as perilipins all represent possible 
alterations to molecular vibrations [54] [55]. While it may not be possible to deduce specific changes 
in lipids or structure between control and treated cells, it would be possible to note if there are any 
fluctuations in vibration corresponding to common protein or lipid bond conformations[59] [60]. 
Therefore, we endeavored to launch a pilot study the effects of Etn on PC3 cells at a molecular 
level. While the results discussed below are preliminary findings, we believe that, with proper 
standardization, FT-IR could be a valuable technique for screening potential anticancer drugs 
based on the alteration of specific vibrations relating to the lipid metabolism. 
 
5.2 Objectives 
• Evaluate changes within the total molecular composition of prostate cancer cells as a result 
of Etn using FT-IR spectroscopy 
 
5.3 Hypothesis 
Treatment of PC3 cells with Etn results in the dysregulation of Ca2+ signaling and the 
induction of lipolytic pathways, leading to a marked decrease of LD in the cytoplasm. With this 
information in mind, it is only fitting to assume that there is an overall shift in the vibrational 
patterns associated with different macromolecule functional groups within the cell. Therefore, 
wavenumber differences in stretching and vibrational patterns between control and Etn treated 
PC3 cell samples are expected to be observed.  
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5.4 Materials and Methods 
 
Figure 5.4.1 Schematic representation of methodology used for Aim 4 
 
5.4.1 Fourier Transform-Infrared Spectroscopy (FT-IR) 
PC3 cells were cultured on 35 mm dishes in standard conditions (37 C, 5% CO2) until 
90% confluency. Dishes were treated with media containing 2 mg/mL Etn or regular maintenance 
media, as a control. Following 4 hours of treatment, cells were pelleted and washed with cold PBS 
to remove any residue of media or drug. Pellets were resuspended in approximately 20 uL of PBS 
and dotted onto FT-IR transmission coverslips and dried under a gentle vacuum for 20 minutes. 
Sample spectra was acquired on a Varian 600 UMA Fourier Transform Infrared 
Spectrophotometer (FT-IR). A background scan was taken of each slide, and control and 
experimental samples were measured fifteen times per each sample triplicate (N=32 
scans/measurement). Resulting spectra was normalized to the Amide I peak, a rubber band baseline 
correction was applied, and was analyzed for second derivative. 
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5.5 Results 
Fourier Transform Infrared spectroscopy (FT-IR) is a classic analytical technique that 
allows for the observation of vibrational patterns of polar bonds within a molecule. The advantage 
of the technique lies in its ability to detect the vibrations and stretching patterns from the bond 
between any two atoms with differing electronegativities This yields a wealth of information about 
how the atoms within a system of interest interact with each other under normal and experimental 
conditions. Due to the computerized nature of modern FT-IR systems, collected data can be used 
to instantly create second derivative graphs and focus on specific regions of interest to the 
researcher. separate spectra into distinct regions allow for ease of reading and concentrated 
analysis of specific regions. The purpose of this experiment was to determine if the use of Etn as 
an anticancer drug yielded any observable molecular changes in healthy PC3 cells as compared to 
control samples, in an effort to develop a low cost, rapid screening system using FT-IR in the 
future.  
Evaluation of control and Etn-treated samples on the high field of the mid-IR spectra 
(~3100-2800 cm-1), two areas that had significant changes that could be linked to specific 
vibrations (Figure 5.5.1). Peak shifts at ~2960 and ~2872 cm-1 (Red notches on spectra and circles 
on 2nd derivative) represent changes in the symmetrical and asymmetrical vibration of CH3 
molecules, respectively, commonly associated to lipids. This area of the FT-IR spectra is closely 
related to the vibration of hydrophobic bonds within molecules that are less likely to shift due to 
their close interaction to avoid polar substances. Although the high wavenumber region does not 
offer as much information in biological systems as those with lower wavenumbers, the fact that 
there is a shift within this area points to the possibility of larger changes in the remainder of the 
spectra.  
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Within mid-wavenumber field of the mid-IR (~1700-1300 cm-1) contains vibrations of 
bonds that are more polar and hydrophilic in nature, lending itself to molecules such as the charged 
amino acid residues of proteins and parts of the phospholipid backbone. In this area, represented 
in Figure 5.5.2, there are changes apparent in 4 areas of the spectra, reflecting 5 shifts within the 
second derivative spectra. Of particular interest is the shift of peak ~1743 cm-1, which represents 
vibrations of ester bonds within lipids, and the shifts of amide I and II (~1650 and ~1550 cm-1). 
Amide I and II are composed of the overlap of several protein-related vibrations relating to 
secondary structures, such as -helices and -sheets/-rolls, in addition to negatively charged 
amino acids that coordinate sequestration processes and cation exchange. The changes seen in the 
second derivative graphs may hint to a change in protein structure due to Etn treatment.  
The low-wavenumber region of the mid-IR spectra (~1300-900 cm-1) changes relating to 
nucleic acids and phospholipid backbone bonds are observed. The bands appearing at ~1241 and 
1085 cm-1 exhibit a difference in proportion (ratio of band A to band B) and change of shape when 
compared to the control. Finally, this area of the spectra also contains a shift in symmetric 
carbohydrate vibration (C-O-O-C, ~975 cm-1). Together these changes might point towards the 
denaturation of genetic material in Etn-treated cells.  
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Figure 5.5.1 High wavenumber region of FT-IR spectra 
FT-IR spectra of high wavenumber (top) accompanied by second derivative analysis (bottom). 
Areas of dissimilitude between control (black line) and Etn-treated (grey) samples are noted with 
a red notch on spectra and red circles on second derivative graph. Rubber band baseline 
corrected, and spectra normalized to Amide I n=32 scans/sample, N=3. 
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Figure 5.5.2 Mid wavenumber region FT-IR spectra 
FT-IR spectra of mid-region wavenumber (top) accompanied by second derivative analysis 
(bottom). Areas of dissimilitude between control (black line) and Etn-treated (grey) samples are 
noted with a red notch on spectra and red circles on second derivative graph. Rubber band 
baseline corrected, and spectra normalized to Amide I n=32 scans/sample, N=3. 
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Figure 5.5.3 Low wavenumber region FT-IR spectra 
FT-IR spectra of low wavenumber (top) accompanied by second derivative analysis (bottom). 
Areas of dissimilitude between control (black line) and Etn-treated (grey) samples are noted with 
a red notch on spectra and red circles on second derivative graph. Rubber band baseline 
corrected, and spectra normalized to Amide I n=32 scans/sample, N=3.  
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5.6 Discussion 
FT-IR is a high resolution, high sensitivity technique that allows for the observation of 
vibrational patterns of polar bonds within a molecule. Moreover, this technique allows for the 
identification of subtle changes in these vibrational patterns due to treatment or experimental 
procedure when compared against a control. Changes in bond length, bond strength, participating 
atoms, or changes within the electronegativity of neighboring bonds can all influence the FT-IR 
spectra, making it one of the most sensitive classical techniques available to biochemists. Through 
computerized analysis of the resulting spectra, a second derivative graph can be created in order 
to more readily identify disruptions without the added step of attempting to deconvolute 
overlapping peaks.  
High wavenumber regions of the mid-IR spectra care associated with vibrations of 
molecules. They include vibrations of C-H, N-H, S-H and O-H interactions. The predominant 
signatures seen are those of C-H interactions, with CH3 and CH2 symmetric and asymmetric 
vibrations being some of the predominant bands. These hydrocarbon bonds are mainly part of 
lipids, non-charged amino acid residues and fatty acid skeletons that help power and construct the 
cell. In the spectra taken from treated and untreated PC3 cells, there are four distinct peaks 
appearing in this region (~3100-2800 cm-1, Figure 5.4.1).  
Two peaks are associated with the asymmetric and vibrations of CH3 and CH2 (~2960 & 
~2924 cm-1), respectively, and the symmetric vibration of the same molecules (~2872 & ~2853 
cm-1). Symmetric and asymmetric vibrations refer to the direction in which the outer atoms move 
in respect to the central atom. In symmetric vibration, outer atoms pull in equal measure outwards 
before snapping back into their original conformation. In asymmetric vibration, the surrounding 
atoms move in different directions from the central atom, causing a disproportionate tilt towards 
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one of the bonds. Peak shifts at ~2960 and ~2872 cm-1 (Red notches on spectra and circles on 2nd 
derivative) represent changes in the symmetrical and asymmetrical vibration of CH3 molecules, 
respectively, commonly associated to lipids. Experiments done on oils with varying degrees of 
saturation exhibited shifts of intensity in these methyl and methylene vibrations. More importantly, 
oils with higher amounts of saturated fatty acids tended to have a 1-2 downward wavenumber 
shift[65]. In Etn-treated cells, signal from symmetric and asymmetric methyl vibrations shifted 
upward in wavenumber compared to the control. With the knowledge that most FAs in cancer cells 
are saturated due to its lack of  12 desaturase it could point towards the cell’s need to import FAs 
from the extracellular environment due to shortage or degradation of intracellular stores.  
Careful analysis of FT-IR spectra of the mid-range wavenumber region (~1700-1300 cm-
1) reveals changes in several vibration patterns. The first change seen is ~1743 cm-1, a peak that 
corresponds to the carbonyl bond, C=O. This bond is commonly in phosphatidyl species (PC, PE, 
PS, in particular)[55]. This wavenumber shift is not surprising to find, as this lab has previously 
shown the change in phospholipid abundance, PE and PC, especially[19]. Another change in this 
region can be observed in the shift in wavenumber for the Amide I peak and subsequent changes 
amount the second derivative of that peak signal. The change observed at ~1650 cm-1 is linked to 
changes within the -helix of the Amide I band. Additionally, three other peaks that are shifted 
under the Amide I and II bands are located on ~1705, ~1560, and ~1575 cm-1.  
The first of these signals corresponds to another carbonyl signal, commonly seen in 
molecules in which H-bonding creates affects cation binding. The other two bands seen 
downstream, ~1560 and ~1575 cm-1 correspond to the asymmetric vibration of the carboxyl groups 
of amino acid resides Asp and Glu that overlap under the Amide II signal. These two amino acids, 
as seen in Aim 2, are known to coordinate the sequestration of Ca2+ within the cell’s ER reserves. 
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This change in wavenumber may be the effect of the ER stores emptying as a result of Etn 
treatment. The -helix motif of the Amide II, seen around ~1548 cm-1 band is also shifted 
compared to the control. Finally, the last signal affected in the mid-wavenumber region 
corresponds to the scissoring of CH2 outside of the vibrational plane of the central atom.  
The low-wavenumber region of the mid-IR spectra (~1300-900 cm-1) is often referred to 
as the fingerprint region of the FT-IR spectra due to the information about carbon skeleton 
bending[59]. It contains holds data pertaining to changes relating to nucleic acids and the 
phospholipid backbone. The peaks seen at ~1241 and ~1085 cm-1 are commonly associated with 
the asymmetric and symmetric phosphodiester bonds of nucleic acids, respectively. The ratio of 
these two bands in the control spectra is (Abs A/Abs B) is ~0.8, while the same ratio in treated 
cells is ~0.7. Taken together with the shift in peak at ~975 cm-1, FT-IR analysis makes a case for 
the effect of Etn as an anticancer agent by not only disruption of lipids and proteins, but through 
the degradation of cell DNA.  
FT-IR is an extremely sensitive technique that helps scientists visualize the vibrations of 
polar bonds shared by two or more atoms. Careful comparison between the spectra for control and 
Etn-treated cells came up with several differences in both the spectra and second derivative 
analysis. Due to the preliminary nature of this analysis, not all differences could be assigned to 
specific groups, apart from those vibrations already well-established in literature. Perhaps, the use 
of different FAs to change the composition of LDs, measuring spectra of cell fractions, rather than 
whole cells and the targeted restriction of the production of certain phospholipids could help 
identify specific peaks against a control. With this information, a library of spectra can be 
composed to use as a reference when screening compounds. 
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5.7 Conclusion 
Previous Aims have given an insight on the fate of the content of the LDs in the cytoplasm 
of PC3 cells following lipolysis. Etn causes the disappearance of LDs in the cytoplasm through an 
increased rate of Ca2+-mediated lipolysis, effectively inhibiting cells to maintain their fast-paced 
rate of growth and proliferation. Although these changes have been observed through validated 
methods in the previous experiments, it was of interest to probe whether there are observable 
differences in the cell’s molecular makeup due to the action of Etn before the cells go into apoptotic 
phase. To make these observations, Etn-treated and control samples were measured through a 
highly sensitive, vibration-based technique known as FT-IR.  
The field of evaluation of biological samples through FT-IR is fairly new. However, many 
strides have been made in the area, including the identification of key regions within the FT-IR 
spectra relating to specific macromolecules and the identification of vibrations and the most likely 
molecules they belong to. Within the breadth of this experiment, changes in the vibrational patterns 
of bonds relating to lipids, protein amino acid residues, protein conformations and nucleic acids 
were observed. Any divergence from the averaged spectra of multiple samples per group represent 
significant change in the molecular makeup of PC3 cells as a result of Etn treatment. While still in 
its preliminary stages of analysis, the sensitivity of this technique makes FT-IR a worthwhile tool 
to test the effectiveness of drugs in the future, following some standardization.  
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6 CONCLUSION AND FUTURE STUDIES 
6.1 Summary and closing remarks 
Cancer cells have developed several metabolic adaptations to ensure their survival and fuel 
their increased proliferation. Among these changes, the most notable are increased glucose through 
the Warburg effect and the creation of their own FAs through de novo lipogenesis. In so, lipid 
metabolism has been well characterized in cancer cells. Due to increased energy demands they 
rely on alternative routes of ATP generation, as is b oxidation. For this purpose, cancer cells have 
adapted to be able to take in FAs from the extracellular environment while also being able to create 
their own and store them in cytosolic reservoirs known as lipid droplets. These lipids can be used 
for energy, building blocks for cell membranes or signaling molecules. While most eukaryotic 
cells contain LDs they are not metabolically active, with the exception of adipocytes, hepatocytes, 
cancer cells and lactating breast tissue, and only have them as emergency reserves.  This makes 
LDs an ideal target for anticancer compounds.  
Etn is a small, polar molecule that serves as a precursor of the Kennedy pathway. Its 
downstream molecules are directly involved in the lipid metabolism of cells. While exogenous Etn 
treatment has been proven to induce apoptotic cell death, the full force of its effects on the lipid 
metabolism of prostate cancer cells have yet to be examined. Our studies have shown that on a 
gross, morphological level, Etn leads to a depletion of LDs in the cell cytoplasm as early as 1 hr 
following treatment and persisting to at least 16 hrs before surviving cell population recuperates 
(Aim 1). With this as a confirmation of change, the next step was to look at changes in signaling 
pathways.  
Calcium is a ubiquitous second messenger within the cell and is involved in nearly all essential 
pathways. Ca2+ homeostasis is important for cell survival, as a dysregulation of [Ca2+]i can have 
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disastrous effects in the cell. High [Ca2+]i can induce cell lipolysis, atrophy genetic material, cause 
the depolarization of the mitochondrial membrane, and induce apoptosis. Here, we demonstrated 
for the first time that Etn activates calcium signaling mechanisms via the release of Ca2+ from 
intracellular stores. This transient increase in Ca2+ was seen in conditions were Ca2+ was and was 
not present in the extracellular environment, meaning that it’s the intracellular reserves that is 
needed to begin the process of cell death. In tandem with the Ca2+ increase, there was an observable 
disruption of the mitochondria membrane potential, characterized by the hyperpolarization and 
subsequent depolarization of the mitochondria (Aim 2). This is especially relevant since it has been 
previously reported that a sustained depolarization of the mitochondria leads to leaking of 
Cytochrome c into the cytosol, making it impossible for ATP to be synthesized, and initiating cell 
death[40].  
In addition to cell death, Ca2+ can be involved in the signaling pathway that induces the 
degradation of cytosolic lipid reserves. Ca2+ causes the activation of PKA through cAMP, leading 
to the hyperphosphorylation of perilipins on the LD surface. This changes the protein’s 
conformation, allowing lipases, such as HSL to degrade the contents of the LDs. The contents 
inside the LDs are broken down in glycerol and free-FAs that excreted or processed by the cell in 
order to survive FA toxicity. Increased glycerol content in the media was seen as early as 1 hr 
following Etn treatment and was sustained until 16 hrs post-treatment, however, the effectiveness 
of Etn was attenuated with the use of Thapsigargin, a Ca2+ channel blocker. These results concur 
with the observation of LD reduction in the cell cytosol in Aim 1 and confirms the stimulation of 
lipolysis through a Ca2+-mediated process (Aim 3).  
Changes being undertaken as a response to Etn treatment are likely to have an effect on the 
molecular makeup of the cell due to the activation of survival and apoptotic pathways. Therefore, 
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it was important to determine these changes through high-resolution techniques. FT-IR is a classic 
vibration-based technique that causes movement through the excitation of bonds through IR 
energy. The resulting movement of polar bonds can be observed on the resulting spectra as a peak. 
Following Etn treatment wavenumber shifts and changes in band shape were observed in peaks 
pertaining lipids, nucleic acids and protein confirmation (Aim 4). Considering that Etn has been 
shown to induce apoptosis, lipolysis and the release of [Ca2+]i, these results are not surprising. 
Although these results are preliminary, the observation of changes between control and Etn-treated 
samples makes FT-IR a valuable resource for drug development.  
In closing, the hypothesis that the effectiveness of Etn was linked to lipid metabolism was 
correct. Etn is an anticancer drug that holds promise as a therapeutic. While traditional medication 
targets cell replication, Etn’s effect on LDs make it an ideal candidate for treatment, as cancer cells 
are more likely to have metabolically active LDs that other normal tissue. Additionally, in previous 
studies with Etn done in the Aneja lab, it has been shown that Etn has a minimal effect on normal 
prostate tissue at the same concentrations in which it would be used as an anticancer therapeutic. 
Etn can be developed as an oral, non-toxic formulation that might reduce patient stress while 
providing faster, more targeted results against cancer.  
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6.2 Further studies 
The mechanism of action of Etn within cancer cells must be completed in order to 
understand exactly why it works. Although Etn has been in use for several decades as a functional 
group for several drugs, how exactly the molecule gets into the cell has not been elucidated. Due 
to the short amount of time needed for Etn to cause an effect on cells following treatment, the 
possibility of specialized transporters or surface receptors is likely. Therefore, systematic 
evaluation of surface cell receptors involved in Ca2+ mediated processes through the use of 
blockers and agonists might be a good avenue to begin investigation. Alternatively, knockouts of 
membrane transporters could yield the answer to how Etn enters the cells. The answer to this 
question may be the missing piece of the therapeutic puzzle that might yield a new generation of 
targeted cancer treatments.  
Additionally, the use of FT-IR in this work has demonstrated that it can detect minute 
changes within the molecular vibrations within cancer cells with a high degree of precision. Further 
than simply understanding that Etn treatment brought along molecular changes, it would be 
interesting to study the turnover of saturated versus unsaturated fatty acids within the cell. The use 
of standards, such as the addition of certain types of fatty acids bound to a transporter in the media 
could help define the shift of essential lipid-related peaks in order to make a quantitative 
comparison between experimental groups. Perhaps the fractionation of treated and control cells 
and separate analysis of different purified components could help eliminate some of the vibrational 
“noise” due to band overlap.  
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APPENDIX 
 
Figure A.1 Extracellular solutions controls for live imaging. 
Control observations for calcium-dependent fluorescence in PC3 cells (A) and mitochondrial 
potential (B). Addition of blank extracellular solution marked by red arrow. 
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Figure A.2 Calcium-dependent fluorescent imaging of PC3 cells.  
Fura-2am fluorescent ratio before, during and after Etn treatment (A-C) shows fluctuation of Ca2+ 
within the cell, according to fluorescent intensity (H). Images before and after treatment in 
brightfield are shown in G & I, and merged in D-F. 
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Figure A.3. Mitochondrial polarization-dependent fluorescent imaging of PC3 cells. 
TMRE fluorescent imaging before, during and after Etn treatment (A-C) shows fluctuation of 
membrane potential in the mitochondria, according to fluorescent intensity (H). Images before 
and after treatment in brightfield are shown in G & I, and merged in D-F. 
 
 
 
